SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-193020
Filing Date
2005-09-28
Accepted
2005-09-28 13:47:43
Documents
5
Period of Report
2005-09-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 20210
2 INDENTURE DATED SEPTEMBER 28, 2005 dex41.htm EX-4.1 611747
3 REGISTRATION RIGHTS AGREEMENT dex42.htm EX-4.2 165239
4 PURCHASE AGREEMENT dex101.htm EX-10.1 163844
5 PRESS RELEASE dex991.htm EX-99.1 5309
  Complete submission text file 0001193125-05-193020.txt   968289
Mailing Address 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 150 INDUSTRIAL RD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 051107528
SIC: 2834 Pharmaceutical Preparations